News zum Sektor Versorger aus Polen

 

Polens Regierung will im Wahljahr 2027 die Steuerzahler entlasten. Um die Reform zu finanzieren, soll die Körperschaftsteuer für Großunternehmen erhöht werden. Energiekonzerne müssen mit Sonderbelastungen rechnen....

Der DAX nimmt erneut das Rekordhoch ins Visier. Sinkende Ölpreise liefern Schub. Der Leitindex gewinnt 0,3 % und schließt bei 26.391 Punkten. Der EuroStoxx50 steigt 0,4 % auf 6.559 Punkte. Der Iran-Krieg bleibt jedoch das zentrale Risiko. Die Wall Street startet verhalten. Rocket Lab verliert rund 4 %. Hohe Ausbaukosten drücken die erwarteten Margen. Hims & Hers fällt rund 2 %. Ein überraschender Quartalsverlust belastet den Telemedizinanbieter. Gespräche zwischen Oman und Iran wecken Hoffnung für die Straße von Hormus. Brent sinkt auf 87,00 US-Dollar. WTI kostet 81,56 US-Dollar. PNE bricht um 19,5 % ein. Zweifel am Unternehmensverkauf vertreiben die Übernahmefantasie. OHB steigt am Donnerstag für Klöckner & Co. in den SDAX auf. Vier Interviews liefern Orientierung. TAG-Co-CEO Martin Thiel erklärt Polens Wohnungsbau und den ROBYG-Börsengang. ATOSS-CFO Christof Leiber spricht über Wachstum und das starke erste Halbjahr. Heiko Thieme warnt vor bösen Sommergewittern. Rückschläge bleiben für...

Das Kohleland Polen baut erneuerbare Energien aus. Die Bevölkerung unterstützt das neuerdings – unter der Bedingung der Versorgungssicherheit....

Tauron's 190MW Miejska Górka wind farm in western Poland will generate enough electricity to supply nearly 200,000 households....

WOIPPY, France--(BUSINESS WIRE)--Regulatory News: ABL Diagnostics (Paris:ABLD) announces that its main shareholder, Advanced Biological Laboratories (ABL), a Luxembourg-based diagnostics company, has filed information with the French Financial Markets Authority (AMF) via ONDE, the centralized information filing system, regarding the sale of a new block of ABL Diagnostics shares as part of an over-the-counter transaction with a private third party. The filing relating to this sale can be viewed in the AMF's database of decisions and financial information (BDIF) at the following address: https://bdif.amf-france.org/fr/details/2026DD1129675. With the support of its main shareholder, ABL, ABL Diagnostics is continuing its efforts to enhance its visibility among all stakeholders (investors, partners, customers, and employees). About ABL Diagnostics (ABLD) ABL Diagnostics (ABLD) is an international company that specializes in innovative molecular biology tests and global solutions for its customers: Molecular ...

DANZIG (dpa-AFX) - Polen hat seinen ersten Windkraftpark auf der Ostsee in Betrieb genommen. Ministerpräsident Donald Tusk sprach von einem Schlüsselelement für die Energiesicherheit des Landes, wie die Nachrichtenagentur PAP meldete. An Land kommt der ......

TORONTO, July 10, 2026 (GLOBE NEWSWIRE) -- Northland Power Inc. (“Northland” or the “Company”) (TSX: NPI) today announced that Baltic Power – its 1.1-gigawatt offshore wind project, owned 49% by Northland and 51% by ORLEN – has achieved first power, delivering the first electricity ever generated from offshore wind to Poland's national grid....

WOIPPY, France--(BUSINESS WIRE)--Regulatory News: ABL Diagnostics (Paris:ABLD) announces that its main shareholder, Advanced Biological Laboratories (ABL), a Luxembourg-based diagnostics company, has filed information with the French Financial Markets Authority (AMF) via ONDE, the centralized information filing system, regarding the sale of a new block of ABL Diagnostics shares as part of an over-the-counter transaction with a private third party. The filing relating to this sale can be viewed in the AMF's database of decisions and financial information (BDIF) at the following address: https://bdif.amf-france.org/fr/details/2026DD1125268. With the support of its main shareholder, ABL, ABL Diagnostics is continuing its efforts to enhance its visibility among all stakeholders (investors, partners, customers, and employees). About ABL Diagnostics (ABLD) ABL Diagnostics (ABLD) is an international company that specializes in innovative molecular biology tests and global solutions for its customers: Molecular ...

WOIPPY, France--(BUSINESS WIRE)--Regulatory News: ABL Diagnostics (Paris:ABLD) announces that its main shareholder, Advanced Biological Laboratories (ABL), a Luxembourg-based diagnostics company, has filed information with the French Financial Markets Authority (AMF) via ONDE, the centralized information filing system, regarding the sale of a new block of ABL Diagnostics shares as part of an over-the-counter transaction with a private third party. The filing relating to this sale can be viewed in the AMF's database of decisions and financial information (BDIF) at the following address: https://bdif.amf-france.org/fr/details/2026DD1118776. With the support of its main shareholder, ABL, ABL Diagnostics is continuing its efforts to enhance its visibility among all stakeholders (investors, partners, customers, and employees). About ABL Diagnostics (ABLD) ABL Diagnostics (ABLD) is an international company that specializes in innovative molecular biology tests and global solutions for its customers: Molecular ...

WOIPPY, France--(BUSINESS WIRE)--Regulatory News: ABL Diagnostics (Paris:ABLD) announces that its main shareholder, Advanced Biological Laboratories (ABL), a Luxembourg-based diagnostics company, has filed information with the French Financial Markets Authority (AMF) via ONDE, the centralized information filing system, regarding the sale of a new block of ABL Diagnostics shares as part of an over-the-counter transaction with a private third party. The filing relating to this sale can be viewed in the AMF's database of decisions and financial information (BDIF) at the following address: https://bdif.amf-france.org/fr/details/2026DD1117613. With the support of its main shareholder, ABL, ABL Diagnostics is continuing its efforts to enhance its visibility among all stakeholders (investors, partners, customers, and employees). About ABL Diagnostics (ABLD) ABL Diagnostics (ABLD) is an international company that specializes in innovative molecular biology tests and global solutions for its customers: Molecular ...

Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

WOIPPY, France--(BUSINESS WIRE)--Regulatory News: ABL Diagnostics (Paris:ABLD) announces that its main shareholder, Advanced Biological Laboratories (ABL), a Luxembourg-based diagnostics company, has filed information with the French Financial Markets Authority (AMF) via ONDE, the centralized information filing system, regarding the sale of a new block of ABL Diagnostics shares as part of an over-the-counter transaction with a private third party. The filing relating to this sale can be viewed in the AMF's database of decisions and financial information (BDIF) at the following address: https://bdif.amf-france.org/fr/details/2026DD1100972. With the support of its main shareholder, ABL, ABL Diagnostics is continuing its efforts to enhance its visibility among all stakeholders (investors, partners, customers, and employees). About ABL Diagnostics (ABLD) ABL Diagnostics (ABLD) is an international company that specializes in innovative molecular biology tests and global solutions for its customers: Molecular ...

WOIPPY, France--(BUSINESS WIRE)--Regulatory News: ABL Diagnostics (Paris:ABLD) announces that its main shareholder, Advanced Biological Laboratories (ABL), a Luxembourg-based diagnostics company, has filed information with the French Financial Markets Authority (AMF) via ONDE, the centralized information filing system, regarding the sale of a new block of ABL Diagnostics shares as part of an over-the-counter transaction with a private third party. The filing relating to this sale can be viewed in the AMF's database of decisions and financial information (BDIF) at the following address: https://bdif.amf-france.org/fr/details/2026DD1092130. With the support of its main shareholder, ABL, ABL Diagnostics is continuing its efforts to enhance its visibility among all stakeholders (investors, partners, customers, and employees). About ABL Diagnostics (ABLD) ABL Diagnostics (ABLD) is an international company that specializes in innovative molecular biology tests and global solutions for its customers: Molecular ...

Polen setzt auf Kernenergie und baut sein erstes Atomkraftwerk an der Ostsee. Die Regierung fördert das Projekt massiv, über 90 Prozent der Bevölkerung befürworten den Einstieg. „Das Kraftwerk kann bis zu 22 Millionen Menschen versorgen“, erklärt Polen-Korrespondent Philipp Fritz....

Während Deutschland aus der Kernenergie ausgestiegen ist, setzt Polen auf den Einstieg: An der Ostseeküste entsteht das erste polnische Atomkraftwerk....

Während Deutschland die Atomenergie hinter sich gelassen hat, steigt Polen erst ein. Das Nachbarland will ein AKW in Ostseenähe bauen - auch um aus der Kohleverstromung auszusteigen. Aus Brüssel gibt es nun grünes Licht. Von David Zajonz....

Deutschland steigt aus, Polen steigt ein: In Ostsee-Nähe soll bis 2033 das erste AKW des Landes entstehen. Brüssel erlaubt nun einen Zuschuss der polnischen Regierung....

The European Commission will on Tuesday approve Poland's plan to provide state aid for its first nuclear power plant, Prime Minister Donald Tusk said....

Poland's biggest energy utility PGE SA ousted Chief Executive Officer Dariusz Marzec a week before a regulatory decision on electricity bills....